AU5551394A - Combined analgesic delivery methods for pain management - Google Patents

Combined analgesic delivery methods for pain management

Info

Publication number
AU5551394A
AU5551394A AU55513/94A AU5551394A AU5551394A AU 5551394 A AU5551394 A AU 5551394A AU 55513/94 A AU55513/94 A AU 55513/94A AU 5551394 A AU5551394 A AU 5551394A AU 5551394 A AU5551394 A AU 5551394A
Authority
AU
Australia
Prior art keywords
delivery methods
pain management
analgesic delivery
combined analgesic
combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55513/94A
Inventor
Richard W. Baker
Michael L Francoeur
Giancarlo Santus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmetrix Corp
Original Assignee
Pharmetrix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US008005 priority Critical
Priority to US97380192A priority
Priority to US973801 priority
Priority to US800593A priority
Application filed by Pharmetrix Corp filed Critical Pharmetrix Corp
Priority to PCT/US1993/010762 priority patent/WO1994010987A1/en
Publication of AU5551394A publication Critical patent/AU5551394A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
AU55513/94A 1992-11-09 1993-11-09 Combined analgesic delivery methods for pain management Abandoned AU5551394A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US008005 1979-01-31
US97380192A true 1992-11-09 1992-11-09
US973801 1992-11-09
US800593A true 1993-01-22 1993-01-22
PCT/US1993/010762 WO1994010987A1 (en) 1992-11-09 1993-11-09 Combined analgesic delivery methods for pain management

Publications (1)

Publication Number Publication Date
AU5551394A true AU5551394A (en) 1994-06-08

Family

ID=26677630

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55513/94A Abandoned AU5551394A (en) 1992-11-09 1993-11-09 Combined analgesic delivery methods for pain management

Country Status (2)

Country Link
AU (1) AU5551394A (en)
WO (1) WO1994010987A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
DE19642043A1 (en) * 1995-10-23 1997-04-24 Hexal Ag Transdermal therapeutic system for treating drug dependency
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
EP0952869A1 (en) * 1997-09-08 1999-11-03 Becton Dickinson and Company Iontophoretic delivery of buprenorphine
EP1036561A1 (en) 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Buccal, non-polar spray
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
KR100289471B1 (en) * 1998-01-19 2001-02-20 김충섭 A controlled/sustained implant delivery containing fentanyls
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
ES2427976T3 (en) 2000-07-31 2013-11-05 Takeda Pharma A/S Fentanyl salt composition for nasal administration
DE10064219B9 (en) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh New fentanyl and / or its derivatives containing pharmaceutical composition for nasal administration
US7666876B2 (en) 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
DE60318041T2 (en) * 2002-05-16 2008-11-27 N.V. Organon Synergistic combination of a Opiatanalgetikums and one NSAID's
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US20040180915A1 (en) * 2003-03-14 2004-09-16 Xanodyne Pharmacal, Inc. Methadone-containing compositions for parenteral administration and method of use thereof
MEP25008A (en) * 2004-04-29 2010-10-10 Caldwell Galer Inc Topical methadone compositions and methods for using the same
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2012127497A1 (en) * 2011-03-04 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of ketorolac or salts thereof
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
US4940586A (en) * 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device

Also Published As

Publication number Publication date
WO1994010987A1 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
AU646646B2 (en) Interactive medication delivery system
AU690735B2 (en) Spiro-azabicyclic compounds useful in therapy
AU679889B2 (en) Health care management system
AU692780B2 (en) Therapeutic preparation for inhalation
AU663918B2 (en) Sacral implant system
AU695971C (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor
AU692429B2 (en) Magnetotherapy apparatus
AU688644B2 (en) Electrotransport delivery device
AU679201B2 (en) Compliance meter for respiratory therapy
AU666702B2 (en) Morphinan derivative and medicinal use
AU644925B2 (en) Medicament dispensing device
AU683905B2 (en) Device for administering pharmaceutical substances
GB2273660B (en) Drug delivery arrangement
GB2303064B (en) Medicament for nasal administration
AU663231B2 (en) Single use disposable needleless injector
AU695904B2 (en) Medication dispensing device
AU696857B2 (en) Tracheostomy cannula
AU695938B2 (en) Anesthetic vaporizer filling system
AU693078B2 (en) Catheter for injecting medicaments
AU679706B2 (en) Syringe
AU689935B2 (en) Improved bioadhesive pharmaceutical delivery system
AU690587B2 (en) Method for dosing therapeutic compounds
AU681718B2 (en) Device and method for in-line drug delivery
AU688001B2 (en) Therapeutic device
AU684088B2 (en) Novel therapeutic drug delivery systems